4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001209191-22-002253
Options or other derivatives
- Corporate Controller acquired 6,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lorenzo Pierre Corporate Controller | 2022-01-04 | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | D | ||
Loading xslF345X03/doc4.xml…